Nucleic acid probes, sequences and methods for detecting mycobac

Details Nucleic acid probes, sequences and methods for detecting mycobac Nucleic acid probes, sequences and methods for detecting mycobac

1995-06-02

1999-02-16

Marschel, Ardin H.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

436501, 536 221, 536 241, 536 243, 536 2431, 536 2432, 536 2433, 935 77, 935 78, C12Q 168

Patent

active

058719121

ABSTRACT:
Multi-drug resistant strains of Mycobacterium tuberculosis represent a considerable threat to public health worldwide. Resistance to isoniazid (INH), a key component of anti-tuberculosis regimens, is often associated with loss of catalase activity and virulence. The katG gene, encoding HPI catalase-peroxidase, mediates INH-sensitivity and that the high level resistance encountered clinically may be due to deletions, insertions or point mutations which reduce or eliminate the expression of the catalase gene in the chromosomal region encompassing katG. INH-resistant strains of Mycobacterium tuberculosis are detected by nucleic acid hybridization with a unique nucleic acid sequence or by amplification techniques.

Affiliated with

Also associated with

Rating

Nucleic acid probes, sequences and methods for detecting mycobac does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid probes, sequences and methods for detecting mycobac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid probes, sequences and methods for detecting mycobac will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2061011